These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 24280366

  • 1. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity.
    Armbruster CE, Smith SN, Yep A, Mobley HL.
    J Infect Dis; 2014 May 15; 209(10):1524-32. PubMed ID: 24280366
    [Abstract] [Full Text] [Related]

  • 2. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE, Smith SN, Johnson AO, DeOrnellas V, Eaton KA, Yep A, Mody L, Wu W, Mobley HLT.
    Infect Immun; 2017 Feb 15; 85(2):. PubMed ID: 27895127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
    White AN, Learman BS, Brauer AL, Armbruster CE.
    Infect Immun; 2021 Sep 16; 89(10):e0017721. PubMed ID: 34280035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
    Jones BD, Mobley HL.
    Infect Immun; 1987 Sep 16; 55(9):2198-203. PubMed ID: 3623698
    [Abstract] [Full Text] [Related]

  • 10. Association of Proteus mirabilis and Providencia stuartii Infections with Diabetes.
    Rus M, Licker M, Musuroi C, Muntean D, Vulpie S, Magiar O, Sorescu T, Musuroi SI, Voinescu A, Baditoiu LM.
    Medicina (Kaunas); 2022 Feb 11; 58(2):. PubMed ID: 35208593
    [Abstract] [Full Text] [Related]

  • 11. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X, Mobley HL.
    Int J Antimicrob Agents; 2002 Jun 11; 19(6):461-5. PubMed ID: 12135833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters.
    Warren JW.
    Rev Infect Dis; 1986 Jun 11; 8(1):61-7. PubMed ID: 3081988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE, Russell RG, Lockatell CV, Zulty JC, Warren JW, Mobley HL.
    Infect Immun; 1993 Jul 11; 61(7):2748-54. PubMed ID: 8514376
    [Abstract] [Full Text] [Related]

  • 17. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
    Hollick GE, Nolte FS, Calnan BJ, Penner JL, Barton LJ, Spellacy A.
    Eur J Clin Microbiol; 1984 Dec 11; 3(6):521-5. PubMed ID: 6526019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I, Stringer AM, Smith SN, Bae E, Mobley HLT, Wade JT, Pearson MM.
    Infect Immun; 2018 Oct 11; 86(10):. PubMed ID: 30082479
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.